Knee Cartilage Repair Global Market Report 2024

The knee cartilage repair market size has grown strongly in recent years. It will grow from $2.73 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the emergence of personalized medicine, advancements in surgical techniques, economic factors and healthcare spending, increased clinical research and trials, and globalization of healthcare.

The knee cartilage repair market size is expected to see strong growth in the next few years. It will grow to $3.8 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The projected expansion in the forecast period can be credited to progress in biomechanical studies, improvements in imaging and diagnostic techniques, heightened awareness regarding post-traumatic osteoarthritis, governmental financial support and grants, and innovations in medical devices. Significant trends anticipated in the forecast period involve patient-focused healthcare, breakthroughs in regenerative medicine, the development of scaffold-based therapies, the rise of tissue engineering solutions, and personalized medicine strategies.

The anticipated increase in sports-related injuries is poised to drive the expansion of the knee cartilage repair market in the future. Sports-related injuries encompass harm sustained during engagement in sports or physical activities. The escalation in such injuries is linked to heightened participation in sports and physical endeavors, intensified training regimens, and insufficient preventive measures. Knee cartilage repair is gaining prominence in addressing injuries stemming from repetitive stress, trauma, and overuse in sports-related incidents. It facilitates the restoration of knee function, alleviation of discomfort, and resumption of athletic pursuits with diminished risks of enduring complications. For example, as per data from the National Safety Council, approximately 3.6 million individuals received treatment in emergency departments for injuries involving sports and recreational equipment in June 2023. Moreover, the incidence of injuries related to sports and recreational equipment rose from 409,224 in 2021 to 445,642 in 2022. Consequently, the surge in sports-related injuries is fostering the expansion of the knee cartilage repair market.

Leading companies within the knee cartilage repair market are directing their efforts towards the development of innovative offerings, such as knee cartilage repair implants, to enhance their competitive position in the industry. Knee cartilage repair implants constitute medical apparatus utilized in orthopedic interventions to facilitate the restoration and rejuvenation of impaired knee cartilage. For instance, in March 2024, UC Davis Health, a prominent medical institution based in the United States, introduced the MISHA Knee System, an implant designed specifically for knee cartilage repair. This system, constructed from resorbable materials, serves to foster cartilage regeneration within the knee. By instigating the body's innate healing mechanisms, the implant promotes the growth and integration of new cartilage and bone tissue over time.

In January 2024, Smith & Nephew plc, a medical equipment company headquartered in the UK, purchased CartiHeal Ltd. for $180 million. Through this acquisition, Smith & Nephew consolidates its commitment to bolstering its thriving sports medicine division and improving its knee repair product range, with the goal of revolutionizing cartilage repair results. CartiHeal Ltd. is a medical device company based in the US renowned for its innovative knee cartilage repair technology.

Major companies operating in the knee cartilage repair market are Stryker Corporation, B. Braun Melsungen AG, DePuy Synthes, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Integra LifeSciences, Bioventus LLC, MTF Biologics, MiMedx Group Inc., Moximed Inc., Vericel Corporation, Anika Therapeutics Inc., SeaSpine Holdings Corporation, LifeNet Health, ConforMIS Inc., Geistlich Pharma AG, BioPoly LLC, Regen Lab SA, Octane Medical Group Inc., Orthocell Limited, Episurf Medical AB.

North America was the largest region in the knee cartilage repair market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee cartilage repair market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the knee cartilage repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Knee cartilage repair encompasses various medical interventions intended to address damaged or deteriorated cartilage within the knee joint, with the goal of reducing pain, enhancing knee functionality, and slowing or halting joint degeneration.

The primary categories of devices for knee cartilage repair include implants, osteotomy, bone grafts, arthroscopy, resurfacing, arthrodesis, and additional types. Implants are synthetic structures surgically inserted into the knee joint to substitute for damaged or absent cartilage. They are utilized in procedures such as arthroscopic chondroplasty, autologous chondrocyte implantation, cell-based cartilage resurfacing, osteochondral graft transplantation, among others, and are employed by various end-users, predominantly hospitals, ambulatory surgical centers, and orthopedic clinics.

The knee cartilage repair market research report is one of a series of new reports that provides knee cartilage repair market statistics, including knee cartilage repair industry global market size, regional shares, competitors with a knee cartilage repair market share, detailed knee cartilage repair market segments, market trends and opportunities, and any further data you may need to thrive in the knee cartilage repair industry. This knee cartilage repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The knee cartilage repair market consists of revenues earned by entities by providing services such as physical therapy, stem cell therapy, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee cartilage repair market also includes sales of osteochondral graft transplantation materials, non-steroidal anti-inflammatory medications, autologous chondrocyte implantation kits, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.